All coronavirus articles
-
OpinionClassifications, racial discrimination and Covid-19
Lessons with philosophical significance for how we group people and objects
-
OpinionChemists amid coronavirus five years on
Rebecca Trager catches up with four chemists to see how their working lives have changed since the start of the Covid-19 pandemic
-
OpinionChemists amid coronavirus five years on: Krystle McLaughlin
An assistant chemistry professor at a small college in New York gets her career back on track, thanks to a tenure clock extension and teaching release
-
OpinionChemists amid coronavirus five years on: Anya Gryn’ova
A computational chemist has moved from being group leader at a German research institute to an associate computational chemistry prof in the UK
-
OpinionChemists amid coronavirus five years on: Liang Zhang
Lockdown gave a young chemistry professor in China the space and time to consider the most worthwhile projects, and that has benefited his team
-
OpinionChemists amid coronavirus five years on: Lee Cronin
A University of Glasgow chemist describes how Covid-19 helped establish the principle of chemputation and spur a chemistry revolution
-
OpinionForming bonds through Covid-19
How studying chemistry helped ward off loneliness during the pandemic
-
BusinessNew Covid-19 antiviral cuts symptoms by 1.5 days
Simnotrelvir already has emergency approval in China
-
OpinionSetting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
-
BusinessPharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
BusinessProtective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
-
BusinessWhat is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
-
NewsUK’s non-profit vaccine manufacturing centre sold off before opening
Pharmaceutical firm Catalent buys government-backed facility near Oxford
-
BusinessModerna sued over Covid-19 vaccine-related patents
Arbutus and Genevant say lipid nanoparticles that protect mRNA infringe six key patents
-
OpinionLiving through Covid-19
Many researchers are now feeling the effects of additional emotional burdens
-
NewsExplainer: How do the Covid vaccines measure up against each other and omicron?
Looking at how the evidence stacks up for vaccines against variants and how their performance holds up over time
-
OpinionThe shadow of drug resistance
Why do some medicines stop working, and can we avoid it for Covid-19 antivirals?
-
CareersThe conference conundrum
Following the Covid-19 pandemic, is it time to rethink events for good?
-
BusinessPharmaceuticals roundup 2021
It’s been another dramatic, pandemic-dominated year for the pharmaceutical industry
-
BusinessCovid-19 antivirals surge forward
Promising results from Pfizer trial, while UK approves Merck & Co’s molnupiravir